Key facts
- Alnylam Pharmaceuticals director Charles L. Pyott sold 8,000 shares.
- The stock sale was valued at approximately $1.15 million.
- The transaction was disclosed in a filing with the U.S. Securities and Exchange Commission.
Charles L. Pyott, a director at Alnylam Pharmaceuticals, has sold 8,000 shares of the company's common stock. The total value of this transaction is approximately $1.15 million. This sale has been officially disclosed through a filing with the U.S. Securities and Exchange Commission.